TORONTO, June 5 /PRNewswire/ -- Genzyme Corporation , one of the world's leading biotechnology companies, is enhancing the quality of the medical devices produced in its Bio-surgery
division with software from Dyadem, the leader in Risk Lifecycle Management and Quality Lifecycle Management.
The fund will also invest in companies developing "platform" technologies within such areas as genomics, proteomics, computational chemistry, and bio-surgery
With more than 300 employees spanning three sites in the United States, Genzyme's Bio-surgery
division now has a single standard for risk assessment.
By adding Bioseal to the existing line of Ethicon hemostasis products sold in China, we aspire to shape the broader bio-surgery
market in Asia by providing physicians and their patients with an even greater variety of innovative and clinical-based solutions to address bleeding, sealing and leaking challenges," said Michael del Prado, company group chairman of JNJ Medical Asia Pacific.
Steven has been involved in all aspects of acquisitions, divestitures, and was instrumental in the purchase of technologies in minimally invasive, electro-surgical, orthopedic and bio-surgery
She was the Therapeutic Area Head of the Bio-Surgery
Division, at the time of her retirement in July of 2011.
is the world's most successful regenerative medicine company and is focused in areas of bio-active wound healing, bio-surgery